Cheapest Tirzepatide in 2026

In 2026 the cheapest FDA-approved route is usually brand Zepbound self-pay direct from Lilly: $299/month at the 2.5 mg starting dose, $399 at 5 mg, and $449/month at maintenance doses (7.5–15 mg) — but that maintenance price holds only if you buy each refill within 45 days of the last one; miss the window and it is $499–$699/month. An insured copay can be lower if your plan covers it. Compounded tirzepatide was the budget route but is now restricted after the shortage ended and is not FDA-approved.

It used to be much cheaper, but the gap has narrowed: Lilly's self-pay program brought brand Zepbound down to $299–$449/month if you keep the 45-day refill schedule ($499–$699 without it), while compounded tirzepatide is being restricted (the shortage is resolved and the FDA is limiting large-scale compounding). Compounded is not FDA-approved and quality varies — for many people brand self-pay is now the better value.

Check insurance first (a telehealth provider can run benefits and prior authorization), use LillyDirect self-pay vials for the lowest brand price, and compare telehealth providers on total monthly cost. To keep LillyDirect’s $449 ceiling on higher doses, refill within 45 days of your last delivery.

The lowest sticker price is brand Zepbound self-pay from Lilly ($299–$449/month with 45-day refills), but the cheapest option for YOU depends on insurance, dose, and whether you want a bundled telehealth program. For the full price reference by dose, see our tirzepatide price guide.